Live from the NIH registry
Studies recruiting near Beaumont right now
Top 25 of 49 recruiting studies, sorted by proximity — each links to its official registry page
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
MW Clinical Research Center — Beaumont, Texas (2.6 mi)
· Sponsor: CSL Behring
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Beaumont, Texas (2.6 mi)
· Sponsor: Alnylam Pharmaceuticals
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Diabetes Mellitus, Type 2, PreDiabetes
N/A
Interventional 7,500 participants sought
Gadolin Research — Beaumont, Texas (2.6 mi)
· Sponsor: Cleerly, Inc.
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
Colon Cancer, Rectal Cancer
Phase 2
Interventional 60 participants sought
Texas Oncology - Gulf Coast — Beaumont, Texas (2.6 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Phase 2, Phase 3
Interventional 690 participants sought
Texas Oncology — Beaumont, Texas (2.6 mi)
· Sponsor: Bristol-Myers Squibb
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Peripheral Arterial Disease
N/A
Interventional 159 participants sought
Nextstage Clinical Research - Beaumont — Beaumont, Texas (2.6 mi)
· Sponsor: Nipro Vascular Innovations Americas, Inc
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Migraine
Phase 3
Interventional 1,059 participants sought
Tekton Research - Beaumont /ID# 231207 — Beaumont, Texas (2.6 mi)
· Sponsor: AbbVie
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Cognitive Dysfunction, Lewy Body Disease
Phase 2
Interventional 350 participants sought
Gadolin Research — Beaumont, Texas (2.6 mi)
· Sponsor: Eli Lilly and Company
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Migraine
Phase 3
Interventional 1,500 participants sought
Gadolin Research, LLC — Beaumont, Texas (2.6 mi)
· Sponsor: TriGemX Bio, Inc.
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
NextStage Clinical Research — Beaumont, Texas (2.6 mi)
· Sponsor: Boehringer Ingelheim
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Chickenpox
Phase 3
Interventional 1,840 participants sought
GSK Investigational Site — Beaumont, Texas (2.6 mi)
· Sponsor: GlaxoSmithKline
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Agitation, Alzheimer's Type Dementia
Phase 3
Interventional 375 participants sought
Gadolin Research — Beaumont, Texas (2.6 mi)
· Sponsor: Suven Life Sciences Limited
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Phase 3
Interventional 160 participants sought
REX Clinical Trials LLC — Beaumont, Texas (2.6 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
Phase 1, Phase 2
Interventional 231 participants sought
Research Site — Beaumont, Texas (2.6 mi)
· Sponsor: AstraZeneca
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Diabetes Mellitus, Type 2
Phase 3
Interventional 170 participants sought
Gadolin Research — Beaumont, Texas (2.6 mi)
· Sponsor: Eli Lilly and Company
A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.
Chikungunya Virus
Phase 3
Interventional 720 participants sought
KidCare Pediatrics — Beaumont, Texas (2.6 mi)
· Sponsor: Bavarian Nordic
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age
SARS-CoV-2
Phase 2
Interventional 300 participants sought
REX Clinical Trials — Beaumont, Texas (2.6 mi)
· Sponsor: ModernaTX, Inc.
Longitudinal Study of Retinal Function in Eyes Treated for Diabetic Macular Edema With Anti-VEGF Agents
Diabetic Retinal Disease
Phase 4
Interventional 100 participants sought
Retina Consultants of Texas — Beaumont, Texas (2.6 mi)
· Sponsor: Jaeb Center for Health Research
Longitudinal Natural History Study of Retinal Function in Eyes of Patients With Diabetes
Diabetic Retinal Disease
N/A
Observational 450 participants sought
Retina Consultants of Texas — Beaumont, Texas (2.6 mi)
· Sponsor: Jaeb Center for Health Research
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Alzheimers Disease
Phase 3
Interventional 80,000 participants sought
Gadolin Research, LLC — Beaumont, Texas (2.6 mi)
· Sponsor: Hoffmann-La Roche
ALTO-100 in Bipolar Disorder With Depression (BD-D)
Bipolar Disorder I or II With a Major Depressive Episode
Phase 2
Interventional 200 participants sought
Site 6105 — Beaumont, Texas (2.6 mi)
· Sponsor: Alto Neuroscience
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD)
Phase 2
Interventional 324 participants sought
Retina Consultants of Texas — Beaumont, Texas (2.6 mi)
· Sponsor: ONL Therapeutics
A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts
Influenza
Phase 3
Interventional 1,100 participants sought
Tekton Research - Beaumont — Beaumont, Texas (2.6 mi)
· Sponsor: Hoffmann-La Roche
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
Major Depressive Disorder
Phase 2
Interventional 230 participants sought
Autobahn Site #153 — Beaumont, Texas (2.6 mi)
· Sponsor: Autobahn Therapeutics, Inc.
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Alzheimer Disease, Dementia
Phase 3
Interventional 550 participants sought
Gadolin Research — Beaumont, Texas (2.6 mi)
· Sponsor: Eli Lilly and Company